[Early detection of chronic polyarthritis. Does early treatment change the course?].
Zeidler
H
H
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000032:analysis; D012460:Sulfasalazine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D006046:Gold; D012217:Rheumatoid Factor; D010396:Penicillamine
Früherkennung der chronischen Polyarthritis. Andert eine Frühbehandlung den Verlauf?